Virological Effectiveness of Dolutegravir Plus Darunavir in People with Multi-Drug-Resistant HIV: Data from the PRESTIGIO Registry
Filippo Lagi(Policlinico Umberto I), Marcello Feasi(Ente Ospedaliero Ospedali Galliera), Tommaso Clemente(Vita-Salute San Raffaele University), Roberto Gulminetti(University of Pavia), Emanuele Focà(Azienda Socio Sanitaria Territoriale degli Spedali Civili di Brescia), Leonardo Calza(University of Bologna), Antonella Castagna(Vita-Salute San Raffaele University), Barbara Menzaghi(Ospedale di Circolo di Busto Arsizio), Seble Tekle Kiros(University of Florence), Rebecka Papaioannu Borjesson(Vita-Salute San Raffaele University), Vincenzo Spagnuolo(Vita-Salute San Raffaele University), Michele Bellomo(Vita-Salute San Raffaele University), Riccardo Lolatto(Vita-Salute San Raffaele University), Filippo Ducci(Azienda Ospedaliero-Universitaria Careggi)
Cited by 1
Related Papers
Steroid‐Responsive Encephalitis in Coronavirus Disease 2019
|Annals of Neurology|2020|299
Fast reshaping of intensive care unit facilities in a large metropolitan hospital in Milan, Italy: facing the COVID-19 pandemic emergency
|Critical Care and Resuscitation|2020|229
Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Encephalitis Is a Cytokine Release Syndrome: Evidences From Cerebrospinal Fluid Analyses
|Clinical Infectious Diseases|2021|179
Mpox in people with past infection or a complete vaccination course: a global case series
|The Lancet Infectious Diseases|2023|141
Real-world effectiveness and safety of glecaprevir/pibrentasvir in 723 patients with chronic hepatitis C
|Journal of Hepatology|2018|132